
Effects of alpha-interferon on serum beta-2-microglobulin
In lymphatic malignancies serum B2M has significant prognostic value. Interferons (IFNs) have the ability to enhance the expression of class I and II histocompatibility antigens. Accordingly, …
The Implication and Significance of Beta 2 Microglobulin: A ...
β2M expresses at a constant level in many cells, however, the formation of β2M would be enhanced in the presence of IFN-α. β2M could induce the expression of interleukin 6 (IL-6), 8 …
Opposing Functions of Interferon Coordinate Adaptive and …
Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade …
Hypoimmunogenic derivatives of induced pluripotent stem cells …
Feb 18, 2019 · B2M −/− CIITA −/− hiPSCs resulted in an IFN-γ release reaching roughly one-third of the spot frequency of the highly NK cell susceptible K562 line, whereas B2M −/− CIITA −/− …
The immune-related role of beta-2-microglobulin in melanoma
Taking into account the many recent advances in B2M-related melanoma immunity, here we discuss the immune function of the B2M gene in tumors, its common genetic alteration in …
Base editing screens map mutations affecting interferon-γ
Jan 19, 2023 · Here, we systematically investigate the genetic determinants of IFN-γ response in colorectal cancer cells using CRISPR-Cas9 screens and base editing mutagenesis.
B2M gene expression shapes the immune landscape of lung adenocarcinoma ...
Our study suggests that genetic and epigenetic regulation of B2M fundamentally shapes the immune landscape of lung adenocarcinomas (LUADs) and determines the response to …
Tumor immune evasion arises through loss of TNF sensitivity
May 4, 2018 · Thus, disruption of antigen presentation is a key mechanism of tumor immune evasion, demonstrated by loss-of-function mutations in the genes encoding β 2-microglobulin …
Beta2-microglobulin (B2M) in cancer immunotherapies: Biological ...
Oct 1, 2021 · B2M mutations have been identified in considerable cancer patients. Increasing evidence has indicated that B2M gene alterations in tumor cells may lower the efficacy of T …
Recurrent immunotherapy failure observed in patients with IFNγ pathway deficiencies. IFNγ signaling pathway and MHC class I regulation require profound molecular understanding to …
- Some results have been removed